[go: up one dir, main page]

SE8505527L - Preparat for forbettring av den cellulera metabolismen - Google Patents

Preparat for forbettring av den cellulera metabolismen

Info

Publication number
SE8505527L
SE8505527L SE8505527A SE8505527A SE8505527L SE 8505527 L SE8505527 L SE 8505527L SE 8505527 A SE8505527 A SE 8505527A SE 8505527 A SE8505527 A SE 8505527A SE 8505527 L SE8505527 L SE 8505527L
Authority
SE
Sweden
Prior art keywords
mmol
composition
conditions
cellular metabolism
overweight
Prior art date
Application number
SE8505527A
Other languages
English (en)
Swedish (sv)
Other versions
SE8505527D0 (sv
SE468074B (sv
Inventor
N C Henningsen
S Jaedig
Original Assignee
Prevent Fa
Medina Hb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevent Fa, Medina Hb filed Critical Prevent Fa
Priority to SE8505527A priority Critical patent/SE468074B/sv
Publication of SE8505527D0 publication Critical patent/SE8505527D0/xx
Priority to AU65133/86A priority patent/AU592385B2/en
Priority to DE198686850396T priority patent/DE223762T1/de
Priority to DE8686850396T priority patent/DE3684882D1/de
Priority to JP61273068A priority patent/JPH07100660B2/ja
Priority to AT86850396T priority patent/ATE74760T1/de
Priority to EP86850396A priority patent/EP0223762B1/en
Priority to NO864682A priority patent/NO175845C/no
Priority to FI864749A priority patent/FI864749A7/fi
Priority to CA000523514A priority patent/CA1275927C/en
Priority to DK560286A priority patent/DK164200C/da
Publication of SE8505527L publication Critical patent/SE8505527L/
Publication of SE468074B publication Critical patent/SE468074B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Special Wing (AREA)
SE8505527A 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen SE468074B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen
AU65133/86A AU592385B2 (en) 1985-11-22 1986-11-14 Composition to improve cellular metabolism
EP86850396A EP0223762B1 (en) 1985-11-22 1986-11-18 Use of a composition for the manufacture of a medicament for the improvement of cellular metabolism
JP61273068A JPH07100660B2 (ja) 1985-11-22 1986-11-18 細胞代謝を向上させる組成物
DE8686850396T DE3684882D1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
DE198686850396T DE223762T1 (de) 1985-11-22 1986-11-18 Zusammensetzung fuer den zellstoffwechsel.
AT86850396T ATE74760T1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
NO864682A NO175845C (no) 1985-11-22 1986-11-21 Anvendelse av kalium-, magnesium- og fosfationer i slankepreparat
FI864749A FI864749A7 (fi) 1985-11-22 1986-11-21 Valmiste solumetabolian parantamiseksi.
CA000523514A CA1275927C (en) 1985-11-22 1986-11-21 Composition to improve cellular metabolism
DK560286A DK164200C (da) 1985-11-22 1986-11-21 Praeparat til forbedring af den cellulaere metabolisme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Publications (3)

Publication Number Publication Date
SE8505527D0 SE8505527D0 (sv) 1985-11-22
SE8505527L true SE8505527L (sv) 1987-05-23
SE468074B SE468074B (sv) 1992-11-02

Family

ID=20362216

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Country Status (10)

Country Link
EP (1) EP0223762B1 ( )
JP (1) JPH07100660B2 ( )
AT (1) ATE74760T1 ( )
AU (1) AU592385B2 ( )
CA (1) CA1275927C ( )
DE (2) DE3684882D1 ( )
DK (1) DK164200C ( )
FI (1) FI864749A7 ( )
NO (1) NO175845C ( )
SE (1) SE468074B ( )

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
DE19925483A1 (de) * 1998-06-04 2000-02-03 Ludwig Schwebel Wirkstoff zur Behandlung der Zuckerkrankheit
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US9585827B2 (en) * 2000-01-21 2017-03-07 The Procter & Gamble Company Kits comprising a beverage composition and information for use
CN102949413B (zh) * 2012-06-08 2014-12-03 辽宁海思科制药有限公司 一种转化糖电解质注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1796976A (en) * 1975-09-23 1978-04-06 Johnson & Johnson Electrolyte mixtures and drinks
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink

Also Published As

Publication number Publication date
DK560286D0 (da) 1986-11-21
NO864682L (no) 1987-05-25
DK164200C (da) 1992-10-19
NO175845B ( ) 1994-09-12
DK560286A (da) 1987-05-23
EP0223762B1 (en) 1992-04-15
NO864682D0 (no) 1986-11-21
CA1275927C (en) 1990-11-06
FI864749A0 (fi) 1986-11-21
NO175845C (no) 1994-12-21
AU592385B2 (en) 1990-01-11
EP0223762A1 (en) 1987-05-27
DK164200B (da) 1992-05-25
AU6513386A (en) 1987-05-28
SE8505527D0 (sv) 1985-11-22
ATE74760T1 (de) 1992-05-15
DE223762T1 (de) 1987-10-15
DE3684882D1 (de) 1992-05-21
JPH07100660B2 (ja) 1995-11-01
SE468074B (sv) 1992-11-02
FI864749L (fi) 1987-05-23
JPS62171654A (ja) 1987-07-28
FI864749A7 (fi) 1987-05-23

Similar Documents

Publication Publication Date Title
Parson et al. Energy needs and growth in children with cystic fibrosis
Bleiler et al. Creatinine excretion: variability and relationships to diet and body size
Stanko et al. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate
Campbell et al. Effects of aerobic exercise and training on the trace minerals chromium, zinc and copper
Brin Effects of thiamine deficiency and of oxythiamine on rat tissue transketolase
Dowdy et al. Copper-molybdenum interaction in sheep and chicks
Garza et al. Human protein requirements: evaluation of the 1973 FAO/WHO safe level of protein intake for young men at high energy intakes
Matzkies et al. The uricosuric action of protein in man
SE8505527L (sv) Preparat for forbettring av den cellulera metabolismen
Paschke et al. Morquio disease, type B: Activation of GM1-β-galactosidase by GM1-activator protein
McArdle Metabolic myopathies: the glycogenoses affecting muscle, and hypo-and hyperkalemic periodic paralysis
Consolazio et al. Dietary carbohydrate and work capacity
Komindr et al. Protein Conservation in Type 2 Diabetic Patients
Briscoe et al. Diurnal variations in calcium and magnesium excretion in man
Song et al. Pantothenic acid status of pregnant and lactating women
Cruickshank et al. A study of available substrates for the endogenous respiration of skin “in vitro.”
Ferroli et al. Bioavailability of vitamin B-6 in young and older men
Xu et al. Wilson's disease (hepatolenticular degeneration): clinical analysis of 80 cases
Fagerberg et al. Weight-reducing diets: role of carbohydrates on sympathetic nervous activity and hypotensive response
TAKEKURA et al. Acute exhaustive exercise changes the metabolic profiles in slow and fast muscles of rat
Chen et al. Zinc attenuation of GDP binding to brown adipocytes mitochondria in genetically obese (ob/ob) mice
RU96121640A (ru) Способ коррекции обменных нарушений у больных сахарным диабетом
Percival et al. Interaction between methionine, fat and choline in the young rat
Richardson et al. The effect of dietary sucrose on protein utilization in healthy young men
KOZYREVSKAIA et al. The effects of different levels of motor activity on sweat electrolyte composition

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8505527-5